These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 18789004

  • 1. [Possibilities of correction of coronary and myocardial reserves in patients with ischemic heart disease by Angiotensin converting enzyme inhibitor perindopril].
    Morozova TE, Vartanova OA, Mikhaĭlova NV.
    Kardiologiia; 2008; 48(8):9-15. PubMed ID: 18789004
    [Abstract] [Full Text] [Related]

  • 2. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G, Nicolosi GL, Chiariello M, Ferrari R, Remme P, Tavazzi L.
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [Abstract] [Full Text] [Related]

  • 3. Effects of perindopril on long-term clinical outcome of patients with coronary artery disease and preserved left ventricular function.
    Bertrand ME, Remme WJ, Fox KM, Ferrari R, Simoons ML, EUROPA investigators.
    Int J Cardiol; 2007 Sep 14; 121(1):57-61. PubMed ID: 17270296
    [Abstract] [Full Text] [Related]

  • 4. [Novel possibilities in the treatment of patients with heart failure. The method of external counterpulsation].
    Gabrusenko SA, Malakhov VV, Sergienko IV, Bugriĭ ME, Saidova MA, Kukharchuk VV, Belenkov IuN.
    Kardiologiia; 2008 Sep 14; 48(9):10-6. PubMed ID: 18991815
    [Abstract] [Full Text] [Related]

  • 5. Influence of perindopril on left ventricular global performance during the early phase of inferior acute myocardial infarction: assessment by Tei index.
    Nearchou NS, Tsakiris AK, Lolaka MD, Zarcos I, Skoufas DP, Skoufas PD.
    Echocardiography; 2003 May 14; 20(4):319-27. PubMed ID: 12848875
    [Abstract] [Full Text] [Related]

  • 6. Effect of quercetin on parameters of central hemodynamics and myocardial ischemia in patients with stable coronary heart disease.
    Chekalina NI, Shut SV, Trybrat TA, Burmak YH, Petrov YY, Manusha YI, Kazakov YM.
    Wiad Lek; 2017 May 14; 70(4):707-711. PubMed ID: 29064791
    [Abstract] [Full Text] [Related]

  • 7. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R, Perindopril and Remodeling in Elderly with Acute Myocardial Infarction Investigators.
    Arch Intern Med; 2006 Mar 27; 166(6):659-66. PubMed ID: 16567606
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Resveratrol is equipotent to perindopril in attenuating post-infarct cardiac remodeling and contractile dysfunction in rats.
    Raj P, Aloud BM, Louis XL, Yu L, Zieroth S, Netticadan T.
    J Nutr Biochem; 2016 Feb 27; 28():155-63. PubMed ID: 26878793
    [Abstract] [Full Text] [Related]

  • 13. [Polymorphism of the ACE gene, structural-functional state of the left ventricle in patients with post-infarction cardiac failure and effects of the ACE-inhibitor Perindopril].
    Tereshchenko SN, Demidova IV, Kobalava ZhD, Moiseev VS.
    Ter Arkh; 2002 Feb 27; 74(4):56-8. PubMed ID: 12043242
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of twelve-month combined therapy with perindopril and indapamide on the level of blood pressure and left ventricular hypertrophy in patients with hypertensive disease].
    Timofeeva LA, Alekhin MN, Ugriumov MO, Chumakova OS, Larina VN, Sidorenko BA.
    Kardiologiia; 2006 Feb 27; 46(3):30-4. PubMed ID: 16710252
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Vascular and myocardial protective effects of converting enzyme inhibition in experimental heart failure.
    Mulder P, Devaux B, el Fertak L, Compagnon P, Richard V, Henry JP, Scalbert E, Desché P, Macé B, Thuillez C.
    Am J Cardiol; 1995 Nov 24; 76(15):28E-33E. PubMed ID: 7484884
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.